Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

The situation with Gerald is that there is better financing out there that is less harmful to shareholders - unfortunately, its difficult to obtain and would be a type of switching of horses / mid-race scenario to perform now, when the Old Boy network dye has long been cast.

"Going forward for MANF, we intend to significantly leverage non-dilutive funding to support MANF product development, especially in secondary programs that will result from the reprioritizing process that we are currently conducting as a result of positive data in orphan indications that has begun to flow in from studies underway. We believe there is a significant appetite among certain disease foundations to support MANF development due to data that has already been generated, and given that we own the composition of matter patents and are moving forward in a product development program, we are in an excellent position to collaborate with the various researchers that have begun to publish on MANF" Gerald Commissiong 09/13/2013

http://globenewswire.com/news-release/2013/09/13/573410/10048467/en/Amarantus-Appoints-F-Randall-Grimes-MBA-as-Director-of-Sponsored-Research.html